生物股份
(600201)
| 流通市值：98.70亿 | | | 总市值：98.70亿 |
| 流通股本：11.20亿 | | | 总股本：11.20亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,218,989,228.41 | 684,715,029.34 | 364,004,443.89 | 1,528,669,256.29 |
| 营业收入 | 1,218,989,228.41 | 684,715,029.34 | 364,004,443.89 | 1,528,669,256.29 |
| 二、营业总成本 | 896,303,403.85 | 533,862,668.25 | 236,832,424.14 | 1,217,058,249.88 |
| 营业成本 | 486,639,705.94 | 290,249,962 | 146,713,745.43 | 685,275,192.61 |
| 税金及附加 | 14,437,320.42 | 10,810,084.28 | 2,803,688.41 | 22,263,531.16 |
| 销售费用 | 230,495,920.89 | 132,633,896.89 | 46,012,920.49 | 294,373,484.1 |
| 管理费用 | 96,634,382.65 | 62,566,848.57 | 28,495,456.5 | 127,394,677.02 |
| 研发费用 | 109,253,292.83 | 64,551,579.64 | 25,934,361.97 | 133,778,931.91 |
| 财务费用 | -41,157,218.88 | -26,949,703.13 | -13,127,748.66 | -46,027,566.92 |
| 其中:利息费用 | 37,112.3 | 33,608.26 | 55,326.66 | 4,814,789.68 |
| 其中:利息收入 | 41,408,525.11 | 27,158,676.87 | 13,219,226.9 | 50,914,363.05 |
| 加:公允价值变动收益 | -117,876.96 | - | - | -4,503,145.82 |
| 加:投资收益 | -445,646.54 | -574,355.64 | -481,294.74 | -5,310,648.62 |
| 资产处置收益 | 219,585.95 | -75,315.65 | - | -44,925.62 |
| 资产减值损失(新) | -7,951,165.72 | -5,998,488 | -1,353,006.51 | -77,038,182.79 |
| 信用减值损失(新) | -11,248,326.25 | -3,528,580.64 | -3,824,372.57 | -1,697,066.11 |
| 其他收益 | 27,719,137.53 | 13,575,782.54 | 7,414,301.18 | 32,081,508.9 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 330,861,532.57 | 154,251,403.7 | 128,927,647.11 | 255,098,546.35 |
| 加:营业外收入 | 492,831.03 | 577,305.91 | 439,981.03 | 2,922,169.04 |
| 减:营业外支出 | 594,141.37 | 389,679.21 | 173,339.84 | 12,436,157.7 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 330,760,222.23 | 154,439,030.4 | 129,194,288.3 | 245,584,557.69 |
| 减:所得税费用 | 45,001,773.8 | 22,123,833.28 | 18,920,473.25 | 45,443,000.77 |
| 六、净利润 | 285,758,448.43 | 132,315,197.12 | 110,273,815.05 | 200,141,556.92 |
| 持续经营净利润 | 285,758,448.43 | 132,315,197.12 | 110,273,815.05 | 200,141,556.92 |
| 归属于母公司股东的净利润 | 288,309,346.9 | 134,425,016.21 | 106,706,586.04 | 210,676,539.06 |
| 少数股东损益 | -2,550,898.47 | -2,109,819.09 | 3,567,229.01 | -10,534,982.14 |
| (一)基本每股收益 | 0.26 | 0.12 | 0.1 | 0.19 |
| (二)稀释每股收益 | 0.26 | 0.12 | - | - |
| 八、其他综合收益 | 208,859.86 | 157,668.23 | 293,089.62 | -170,402.01 |
| 归属于母公司股东的其他综合收益 | 165,242.71 | 165,596.03 | 238,226.59 | -177,363.45 |
| 九、综合收益总额 | 285,967,308.29 | 132,472,865.35 | 110,566,904.67 | 199,971,154.91 |
| 归属于母公司股东的综合收益总额 | 288,474,589.61 | 134,590,612.24 | 106,944,812.63 | 210,499,175.61 |
| 归属于少数股东的综合收益总额 | -2,507,281.32 | -2,117,746.89 | 3,622,092.04 | -10,528,020.7 |
| 公告日期 | 2023-10-31 | 2023-08-25 | 2023-04-21 | 2023-04-21 |
| 审计意见(境内) | | | | 标准无保留意见 |